| GO:0032991 | protein-containing complex | 32.51% (66/203) | 2.81 | 0.0 | 0.0 |
| GO:0016070 | RNA metabolic process | 23.15% (47/203) | 3.25 | 0.0 | 0.0 |
| GO:0005575 | cellular_component | 57.14% (116/203) | 1.52 | 0.0 | 0.0 |
| GO:0140513 | nuclear protein-containing complex | 18.72% (38/203) | 3.65 | 0.0 | 0.0 |
| GO:0035101 | FACT complex | 5.42% (11/203) | 9.41 | 0.0 | 0.0 |
| GO:0005488 | binding | 58.62% (119/203) | 1.38 | 0.0 | 0.0 |
| GO:0090304 | nucleic acid metabolic process | 23.65% (48/203) | 2.56 | 0.0 | 0.0 |
| GO:0006139 | nucleobase-containing compound metabolic process | 25.12% (51/203) | 2.42 | 0.0 | 0.0 |
| GO:0046483 | heterocycle metabolic process | 25.12% (51/203) | 2.32 | 0.0 | 0.0 |
| GO:0006725 | cellular aromatic compound metabolic process | 25.12% (51/203) | 2.29 | 0.0 | 0.0 |
| GO:0031491 | nucleosome binding | 5.91% (12/203) | 6.8 | 0.0 | 0.0 |
| GO:1901360 | organic cyclic compound metabolic process | 25.12% (51/203) | 2.24 | 0.0 | 0.0 |
| GO:0034641 | cellular nitrogen compound metabolic process | 25.12% (51/203) | 2.23 | 0.0 | 0.0 |
| GO:0003676 | nucleic acid binding | 27.59% (56/203) | 2.07 | 0.0 | 0.0 |
| GO:0003723 | RNA binding | 16.75% (34/203) | 2.93 | 0.0 | 0.0 |
| GO:0043170 | macromolecule metabolic process | 34.98% (71/203) | 1.68 | 0.0 | 0.0 |
| GO:0008150 | biological_process | 58.13% (118/203) | 1.06 | 0.0 | 0.0 |
| GO:0006807 | nitrogen compound metabolic process | 36.45% (74/203) | 1.59 | 0.0 | 0.0 |
| GO:0097159 | organic cyclic compound binding | 39.41% (80/203) | 1.46 | 0.0 | 0.0 |
| GO:0044238 | primary metabolic process | 39.41% (80/203) | 1.45 | 0.0 | 0.0 |
| GO:0003674 | molecular_function | 65.52% (133/203) | 0.89 | 0.0 | 0.0 |
| GO:0008023 | transcription elongation factor complex | 5.42% (11/203) | 6.38 | 0.0 | 0.0 |
| GO:0071704 | organic substance metabolic process | 39.41% (80/203) | 1.37 | 0.0 | 0.0 |
| GO:0140098 | catalytic activity, acting on RNA | 11.33% (23/203) | 3.28 | 0.0 | 0.0 |
| GO:0006396 | RNA processing | 11.33% (23/203) | 3.23 | 0.0 | 0.0 |
| GO:0008152 | metabolic process | 39.41% (80/203) | 1.3 | 0.0 | 0.0 |
| GO:0004812 | aminoacyl-tRNA ligase activity | 6.4% (13/203) | 4.81 | 0.0 | 0.0 |
| GO:0016875 | ligase activity, forming carbon-oxygen bonds | 6.4% (13/203) | 4.81 | 0.0 | 0.0 |
| GO:0006418 | tRNA aminoacylation for protein translation | 6.4% (13/203) | 4.81 | 0.0 | 0.0 |
| GO:0034660 | ncRNA metabolic process | 10.34% (21/203) | 3.36 | 0.0 | 0.0 |
| GO:0043039 | tRNA aminoacylation | 6.4% (13/203) | 4.78 | 0.0 | 0.0 |
| GO:0043038 | amino acid activation | 6.4% (13/203) | 4.73 | 0.0 | 0.0 |
| GO:0006399 | tRNA metabolic process | 7.88% (16/203) | 3.97 | 0.0 | 0.0 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 13.3% (27/203) | 2.72 | 0.0 | 0.0 |
| GO:0003682 | chromatin binding | 6.9% (14/203) | 4.36 | 0.0 | 0.0 |
| GO:0006368 | transcription elongation by RNA polymerase II | 3.94% (8/203) | 6.68 | 0.0 | 0.0 |
| GO:0006354 | DNA-templated transcription elongation | 3.94% (8/203) | 6.61 | 0.0 | 0.0 |
| GO:0140101 | catalytic activity, acting on a tRNA | 6.9% (14/203) | 4.25 | 0.0 | 0.0 |
| GO:0006397 | mRNA processing | 6.4% (13/203) | 4.17 | 0.0 | 0.0 |
| GO:0010468 | regulation of gene expression | 14.78% (30/203) | 2.26 | 0.0 | 0.0 |
| GO:0016071 | mRNA metabolic process | 7.39% (15/203) | 3.68 | 0.0 | 0.0 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 14.78% (30/203) | 2.25 | 0.0 | 0.0 |
| GO:0009889 | regulation of biosynthetic process | 14.78% (30/203) | 2.22 | 0.0 | 0.0 |
| GO:0031326 | regulation of cellular biosynthetic process | 14.78% (30/203) | 2.22 | 0.0 | 0.0 |
| GO:0044877 | protein-containing complex binding | 7.88% (16/203) | 3.43 | 0.0 | 0.0 |
| GO:1902494 | catalytic complex | 10.84% (22/203) | 2.72 | 0.0 | 0.0 |
| GO:0060255 | regulation of macromolecule metabolic process | 14.78% (30/203) | 2.12 | 0.0 | 0.0 |
| GO:0031323 | regulation of cellular metabolic process | 14.78% (30/203) | 2.11 | 0.0 | 0.0 |
| GO:0005515 | protein binding | 22.17% (45/203) | 1.57 | 0.0 | 0.0 |
| GO:0019222 | regulation of metabolic process | 14.78% (30/203) | 2.06 | 0.0 | 0.0 |
| GO:0009987 | cellular process | 37.93% (77/203) | 1.04 | 0.0 | 0.0 |
| GO:0016874 | ligase activity | 6.9% (14/203) | 3.39 | 0.0 | 0.0 |
| GO:0110165 | cellular anatomical entity | 36.45% (74/203) | 1.04 | 0.0 | 0.0 |
| GO:0043226 | organelle | 22.66% (46/203) | 1.47 | 0.0 | 0.0 |
| GO:0043229 | intracellular organelle | 22.66% (46/203) | 1.47 | 0.0 | 0.0 |
| GO:0044237 | cellular metabolic process | 28.08% (57/203) | 1.26 | 0.0 | 0.0 |
| GO:1990904 | ribonucleoprotein complex | 7.39% (15/203) | 3.1 | 0.0 | 0.0 |
| GO:0140535 | intracellular protein-containing complex | 7.39% (15/203) | 3.04 | 0.0 | 0.0 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 17.24% (35/203) | 1.7 | 0.0 | 0.0 |
| GO:0034455 | t-UTP complex | 1.97% (4/203) | 7.89 | 0.0 | 0.0 |
| GO:0050794 | regulation of cellular process | 16.26% (33/203) | 1.69 | 0.0 | 0.0 |
| GO:2001141 | regulation of RNA biosynthetic process | 10.84% (22/203) | 2.21 | 0.0 | 0.0 |
| GO:0006355 | regulation of DNA-templated transcription | 10.84% (22/203) | 2.21 | 0.0 | 0.0 |
| GO:0005681 | spliceosomal complex | 4.43% (9/203) | 4.14 | 0.0 | 0.0 |
| GO:0051252 | regulation of RNA metabolic process | 10.84% (22/203) | 2.14 | 0.0 | 0.0 |
| GO:0006520 | amino acid metabolic process | 6.4% (13/203) | 3.05 | 0.0 | 0.0 |
| GO:0050789 | regulation of biological process | 16.26% (33/203) | 1.62 | 0.0 | 0.0 |
| GO:0005634 | nucleus | 13.3% (27/203) | 1.85 | 0.0 | 0.0 |
| GO:0005849 | mRNA cleavage factor complex | 2.46% (5/203) | 6.13 | 0.0 | 0.0 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 10.84% (22/203) | 2.09 | 0.0 | 0.0 |
| GO:0065007 | biological regulation | 16.75% (34/203) | 1.56 | 0.0 | 0.0 |
| GO:0002161 | aminoacyl-tRNA editing activity | 2.46% (5/203) | 6.05 | 0.0 | 0.0 |
| GO:0043227 | membrane-bounded organelle | 18.72% (38/203) | 1.41 | 0.0 | 0.0 |
| GO:0006378 | mRNA polyadenylation | 2.46% (5/203) | 5.79 | 0.0 | 0.0 |
| GO:0032774 | RNA biosynthetic process | 4.93% (10/203) | 3.42 | 0.0 | 1e-06 |
| GO:0006356 | regulation of transcription by RNA polymerase I | 1.97% (4/203) | 6.75 | 0.0 | 1e-06 |
| GO:0045943 | positive regulation of transcription by RNA polymerase I | 1.97% (4/203) | 6.75 | 0.0 | 1e-06 |
| GO:0008334 | histone mRNA metabolic process | 1.97% (4/203) | 6.72 | 0.0 | 1e-06 |
| GO:0043687 | post-translational protein modification | 6.9% (14/203) | 2.65 | 0.0 | 1e-06 |
| GO:0043231 | intracellular membrane-bounded organelle | 18.23% (37/203) | 1.38 | 0.0 | 1e-06 |
| GO:0005524 | ATP binding | 14.78% (30/203) | 1.58 | 0.0 | 1e-06 |
| GO:0004823 | leucine-tRNA ligase activity | 1.97% (4/203) | 6.52 | 0.0 | 1e-06 |
| GO:0006429 | leucyl-tRNA aminoacylation | 1.97% (4/203) | 6.52 | 0.0 | 1e-06 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 10.84% (22/203) | 1.91 | 0.0 | 1e-06 |
| GO:0080090 | regulation of primary metabolic process | 10.84% (22/203) | 1.89 | 0.0 | 2e-06 |
| GO:0000398 | mRNA splicing, via spliceosome | 3.45% (7/203) | 4.13 | 0.0 | 2e-06 |
| GO:0051762 | sesquiterpene biosynthetic process | 1.48% (3/203) | 8.07 | 0.0 | 2e-06 |
| GO:0051761 | sesquiterpene metabolic process | 1.48% (3/203) | 8.07 | 0.0 | 2e-06 |
| GO:0032555 | purine ribonucleotide binding | 17.24% (35/203) | 1.37 | 0.0 | 2e-06 |
| GO:1901564 | organonitrogen compound metabolic process | 19.7% (40/203) | 1.25 | 0.0 | 2e-06 |
| GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.45% (7/203) | 4.05 | 0.0 | 3e-06 |
| GO:0032553 | ribonucleotide binding | 17.24% (35/203) | 1.35 | 0.0 | 3e-06 |
| GO:0031124 | mRNA 3'-end processing | 2.46% (5/203) | 5.2 | 0.0 | 3e-06 |
| GO:0097367 | carbohydrate derivative binding | 17.24% (35/203) | 1.34 | 0.0 | 3e-06 |
| GO:0030515 | snoRNA binding | 2.46% (5/203) | 5.1 | 0.0 | 4e-06 |
| GO:0000375 | RNA splicing, via transesterification reactions | 3.45% (7/203) | 3.93 | 1e-06 | 4e-06 |
| GO:0017076 | purine nucleotide binding | 17.24% (35/203) | 1.31 | 1e-06 | 5e-06 |
| GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage | 1.48% (3/203) | 7.42 | 1e-06 | 7e-06 |
| GO:0005737 | cytoplasm | 10.84% (22/203) | 1.75 | 1e-06 | 7e-06 |
| GO:0004534 | 5'-3' RNA exonuclease activity | 1.48% (3/203) | 7.39 | 1e-06 | 7e-06 |
| GO:0031123 | RNA 3'-end processing | 2.96% (6/203) | 4.22 | 1e-06 | 8e-06 |
| GO:0009975 | cyclase activity | 1.48% (3/203) | 7.28 | 1e-06 | 9e-06 |
| GO:0046246 | terpene biosynthetic process | 1.48% (3/203) | 7.19 | 1e-06 | 1e-05 |
| GO:0120251 | hydrocarbon biosynthetic process | 1.48% (3/203) | 7.19 | 1e-06 | 1e-05 |
| GO:0008380 | RNA splicing | 3.45% (7/203) | 3.7 | 1e-06 | 1.1e-05 |
| GO:0000244 | spliceosomal tri-snRNP complex assembly | 1.48% (3/203) | 7.07 | 2e-06 | 1.3e-05 |
| GO:0000166 | nucleotide binding | 17.24% (35/203) | 1.25 | 2e-06 | 1.3e-05 |
| GO:1901265 | nucleoside phosphate binding | 17.24% (35/203) | 1.25 | 2e-06 | 1.3e-05 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 5.42% (11/203) | 2.66 | 2e-06 | 1.3e-05 |
| GO:0019752 | carboxylic acid metabolic process | 6.9% (14/203) | 2.24 | 2e-06 | 1.5e-05 |
| GO:0044281 | small molecule metabolic process | 8.87% (18/203) | 1.9 | 2e-06 | 1.6e-05 |
| GO:0043436 | oxoacid metabolic process | 6.9% (14/203) | 2.24 | 2e-06 | 1.6e-05 |
| GO:0006082 | organic acid metabolic process | 6.9% (14/203) | 2.24 | 2e-06 | 1.6e-05 |
| GO:0043168 | anion binding | 17.24% (35/203) | 1.22 | 3e-06 | 1.8e-05 |
| GO:0070647 | protein modification by small protein conjugation or removal | 5.42% (11/203) | 2.6 | 3e-06 | 1.9e-05 |
| GO:0003729 | mRNA binding | 4.43% (9/203) | 2.98 | 3e-06 | 2e-05 |
| GO:1901363 | heterocyclic compound binding | 17.24% (35/203) | 1.21 | 3e-06 | 2.1e-05 |
| GO:0022618 | protein-RNA complex assembly | 2.96% (6/203) | 3.92 | 4e-06 | 2.4e-05 |
| GO:0036094 | small molecule binding | 17.24% (35/203) | 1.2 | 4e-06 | 2.4e-05 |
| GO:0043167 | ion binding | 21.18% (43/203) | 1.04 | 4e-06 | 2.5e-05 |
| GO:0004163 | diphosphomevalonate decarboxylase activity | 0.99% (2/203) | 9.36 | 4e-06 | 2.7e-05 |
| GO:0071826 | protein-RNA complex organization | 2.96% (6/203) | 3.88 | 4e-06 | 2.7e-05 |
| GO:0045893 | positive regulation of DNA-templated transcription | 3.45% (7/203) | 3.46 | 4e-06 | 2.8e-05 |
| GO:1902680 | positive regulation of RNA biosynthetic process | 3.45% (7/203) | 3.46 | 4e-06 | 2.8e-05 |
| GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.97% (4/203) | 5.14 | 6e-06 | 3.8e-05 |
| GO:0004832 | valine-tRNA ligase activity | 1.48% (3/203) | 6.4 | 7e-06 | 4.3e-05 |
| GO:0006438 | valyl-tRNA aminoacylation | 1.48% (3/203) | 6.4 | 7e-06 | 4.3e-05 |
| GO:0005832 | chaperonin-containing T-complex | 1.48% (3/203) | 6.39 | 7e-06 | 4.4e-05 |
| GO:0005829 | cytosol | 6.4% (13/203) | 2.17 | 8e-06 | 5.1e-05 |
| GO:0000209 | protein polyubiquitination | 2.46% (5/203) | 4.23 | 8e-06 | 5.2e-05 |
| GO:0005730 | nucleolus | 3.45% (7/203) | 3.31 | 9e-06 | 5.2e-05 |
| GO:0101031 | protein folding chaperone complex | 1.48% (3/203) | 6.23 | 1e-05 | 5.9e-05 |
| GO:0016567 | protein ubiquitination | 4.43% (9/203) | 2.72 | 1.2e-05 | 6.9e-05 |
| GO:0008134 | transcription factor binding | 1.97% (4/203) | 4.86 | 1.3e-05 | 7.7e-05 |
| GO:0000388 | spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) | 0.99% (2/203) | 8.53 | 1.4e-05 | 7.9e-05 |
| GO:0051254 | positive regulation of RNA metabolic process | 3.45% (7/203) | 3.21 | 1.4e-05 | 8e-05 |
| GO:0032559 | adenyl ribonucleotide binding | 14.78% (30/203) | 1.22 | 1.4e-05 | 8.1e-05 |
| GO:0140657 | ATP-dependent activity | 6.9% (14/203) | 1.99 | 1.5e-05 | 8.8e-05 |
| GO:0030686 | 90S preribosome | 1.97% (4/203) | 4.78 | 1.6e-05 | 9e-05 |
| GO:0031328 | positive regulation of cellular biosynthetic process | 3.45% (7/203) | 3.17 | 1.6e-05 | 9.1e-05 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 3.45% (7/203) | 3.17 | 1.6e-05 | 9.1e-05 |
| GO:0009891 | positive regulation of biosynthetic process | 3.45% (7/203) | 3.17 | 1.6e-05 | 9.1e-05 |
| GO:0032446 | protein modification by small protein conjugation | 4.43% (9/203) | 2.64 | 1.8e-05 | 9.8e-05 |
| GO:0030490 | maturation of SSU-rRNA | 1.97% (4/203) | 4.73 | 1.8e-05 | 0.000101 |
| GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.48% (3/203) | 5.93 | 1.9e-05 | 0.000102 |
| GO:0018130 | heterocycle biosynthetic process | 5.42% (11/203) | 2.3 | 1.9e-05 | 0.000102 |
| GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 3.45% (7/203) | 3.13 | 1.9e-05 | 0.000104 |
| GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 1.97% (4/203) | 4.65 | 2.3e-05 | 0.000122 |
| GO:0004532 | RNA exonuclease activity | 1.97% (4/203) | 4.65 | 2.3e-05 | 0.000122 |
| GO:0016788 | hydrolase activity, acting on ester bonds | 6.9% (14/203) | 1.92 | 2.6e-05 | 0.00014 |
| GO:0030554 | adenyl nucleotide binding | 14.78% (30/203) | 1.17 | 2.9e-05 | 0.000151 |
| GO:0019438 | aromatic compound biosynthetic process | 5.42% (11/203) | 2.23 | 3e-05 | 0.000155 |
| GO:0000387 | spliceosomal snRNP assembly | 1.48% (3/203) | 5.63 | 3.4e-05 | 0.000178 |
| GO:0003824 | catalytic activity | 29.56% (60/203) | 0.71 | 4.7e-05 | 0.000243 |
| GO:0016787 | hydrolase activity | 12.81% (26/203) | 1.22 | 5.5e-05 | 0.000284 |
| GO:0004527 | exonuclease activity | 2.46% (5/203) | 3.65 | 5.8e-05 | 0.000296 |
| GO:0031325 | positive regulation of cellular metabolic process | 3.45% (7/203) | 2.86 | 6.3e-05 | 0.000317 |
| GO:0016570 | histone modification | 2.46% (5/203) | 3.62 | 6.3e-05 | 0.000317 |
| GO:0009059 | macromolecule biosynthetic process | 5.42% (11/203) | 2.1 | 6.5e-05 | 0.000324 |
| GO:0008409 | 5'-3' exonuclease activity | 1.48% (3/203) | 5.3 | 6.8e-05 | 0.000339 |
| GO:1901362 | organic cyclic compound biosynthetic process | 5.42% (11/203) | 2.08 | 7.4e-05 | 0.000366 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 5.91% (12/203) | 1.96 | 7.7e-05 | 0.000378 |
| GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 0.99% (2/203) | 7.17 | 9.2e-05 | 0.00045 |
| GO:0071011 | precatalytic spliceosome | 1.48% (3/203) | 5.09 | 0.000104 | 0.000506 |
| GO:0016043 | cellular component organization | 7.88% (16/203) | 1.58 | 0.000117 | 0.000536 |
| GO:0042214 | terpene metabolic process | 1.48% (3/203) | 5.06 | 0.000112 | 0.000537 |
| GO:0031371 | ubiquitin conjugating enzyme complex | 0.99% (2/203) | 7.01 | 0.000116 | 0.000538 |
| GO:0033523 | histone H2B ubiquitination | 0.99% (2/203) | 7.01 | 0.000116 | 0.000538 |
| GO:0033503 | HULC complex | 0.99% (2/203) | 7.01 | 0.000116 | 0.000538 |
| GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 0.99% (2/203) | 7.01 | 0.000116 | 0.000538 |
| GO:0010390 | histone monoubiquitination | 0.99% (2/203) | 7.01 | 0.000116 | 0.000538 |
| GO:0120252 | hydrocarbon metabolic process | 1.48% (3/203) | 5.04 | 0.000114 | 0.000546 |
| GO:0004540 | RNA nuclease activity | 2.96% (6/203) | 3.02 | 0.000115 | 0.000547 |
| GO:0034470 | ncRNA processing | 3.94% (8/203) | 2.45 | 0.000129 | 0.000588 |
| GO:0048522 | positive regulation of cellular process | 3.45% (7/203) | 2.68 | 0.000132 | 0.000602 |
| GO:1901576 | organic substance biosynthetic process | 8.87% (18/203) | 1.44 | 0.000145 | 0.000653 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 3.45% (7/203) | 2.66 | 0.000146 | 0.000655 |
| GO:0009893 | positive regulation of metabolic process | 3.45% (7/203) | 2.64 | 0.000159 | 0.000705 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 3.45% (7/203) | 2.64 | 0.000158 | 0.000707 |
| GO:0030684 | preribosome | 2.46% (5/203) | 3.33 | 0.000162 | 0.000715 |
| GO:0006364 | rRNA processing | 2.96% (6/203) | 2.92 | 0.000166 | 0.000728 |
| GO:0004518 | nuclease activity | 3.45% (7/203) | 2.62 | 0.000168 | 0.000732 |
| GO:0032040 | small-subunit processome | 1.97% (4/203) | 3.89 | 0.000174 | 0.000758 |
| GO:0052689 | carboxylic ester hydrolase activity | 2.46% (5/203) | 3.27 | 0.000195 | 0.000843 |
| GO:0016574 | histone ubiquitination | 0.99% (2/203) | 6.58 | 0.000212 | 0.00091 |
| GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.97% (4/203) | 3.78 | 0.000229 | 0.00098 |
| GO:0000151 | ubiquitin ligase complex | 2.46% (5/203) | 3.21 | 0.000239 | 0.001014 |
| GO:0016072 | rRNA metabolic process | 2.96% (6/203) | 2.81 | 0.000252 | 0.001065 |
| GO:0005687 | U4 snRNP | 0.99% (2/203) | 6.44 | 0.000255 | 0.001072 |
| GO:0043228 | non-membrane-bounded organelle | 4.93% (10/203) | 1.98 | 0.000273 | 0.001123 |
| GO:0042393 | histone binding | 1.97% (4/203) | 3.72 | 0.000271 | 0.001128 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 4.93% (10/203) | 1.98 | 0.000272 | 0.001128 |
| GO:0009058 | biosynthetic process | 8.87% (18/203) | 1.36 | 0.00027 | 0.00113 |
| GO:0009368 | endopeptidase Clp complex | 0.99% (2/203) | 6.36 | 0.000286 | 0.001171 |
| GO:0004521 | RNA endonuclease activity | 2.46% (5/203) | 3.14 | 0.000291 | 0.001179 |
| GO:1905368 | peptidase complex | 1.48% (3/203) | 4.59 | 0.00029 | 0.001183 |
| GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 0.99% (2/203) | 6.3 | 0.00031 | 0.001239 |
| GO:0044784 | metaphase/anaphase transition of cell cycle | 0.99% (2/203) | 6.3 | 0.00031 | 0.001239 |
| GO:0000049 | tRNA binding | 1.48% (3/203) | 4.55 | 0.000309 | 0.001247 |
| GO:0003677 | DNA binding | 7.88% (16/203) | 1.42 | 0.000384 | 0.001525 |
| GO:0071840 | cellular component organization or biogenesis | 7.88% (16/203) | 1.42 | 0.00039 | 0.001542 |
| GO:0048518 | positive regulation of biological process | 3.45% (7/203) | 2.42 | 0.000393 | 0.001546 |
| GO:0005622 | intracellular anatomical structure | 1.48% (3/203) | 4.41 | 0.000411 | 0.00161 |
| GO:0042765 | GPI-anchor transamidase complex | 0.99% (2/203) | 6.02 | 0.000456 | 0.001759 |
| GO:0016255 | attachment of GPI anchor to protein | 0.99% (2/203) | 6.02 | 0.000456 | 0.001759 |
| GO:0008303 | caspase complex | 0.99% (2/203) | 6.02 | 0.000456 | 0.001759 |
| GO:0004842 | ubiquitin-protein transferase activity | 2.96% (6/203) | 2.64 | 0.00046 | 0.001767 |
| GO:0006513 | protein monoubiquitination | 0.99% (2/203) | 5.93 | 0.000518 | 0.001978 |
| GO:0019787 | ubiquitin-like protein transferase activity | 2.96% (6/203) | 2.59 | 0.000552 | 0.002101 |
| GO:0006406 | mRNA export from nucleus | 1.48% (3/203) | 4.25 | 0.000574 | 0.002164 |
| GO:0051028 | mRNA transport | 1.48% (3/203) | 4.25 | 0.000574 | 0.002164 |
| GO:0048284 | organelle fusion | 1.48% (3/203) | 4.22 | 0.000603 | 0.002262 |
| GO:0016755 | aminoacyltransferase activity | 2.96% (6/203) | 2.56 | 0.000623 | 0.002324 |
| GO:1990234 | transferase complex | 3.94% (8/203) | 2.09 | 0.000689 | 0.002548 |
| GO:0000974 | Prp19 complex | 0.99% (2/203) | 5.72 | 0.000689 | 0.002559 |
| GO:0046907 | intracellular transport | 3.94% (8/203) | 2.08 | 0.000698 | 0.002569 |
| GO:0019899 | enzyme binding | 2.46% (5/203) | 2.84 | 0.000742 | 0.002717 |
| GO:0031902 | late endosome membrane | 0.99% (2/203) | 5.65 | 0.000764 | 0.002786 |
| GO:0071013 | catalytic step 2 spliceosome | 1.48% (3/203) | 4.07 | 0.000813 | 0.002952 |
| GO:0009240 | isopentenyl diphosphate biosynthetic process | 0.99% (2/203) | 5.59 | 0.000829 | 0.00297 |
| GO:0051117 | ATPase binding | 0.99% (2/203) | 5.59 | 0.000829 | 0.00297 |
| GO:0046490 | isopentenyl diphosphate metabolic process | 0.99% (2/203) | 5.59 | 0.000829 | 0.00297 |
| GO:0070979 | protein K11-linked ubiquitination | 0.99% (2/203) | 5.55 | 0.00087 | 0.003087 |
| GO:0051649 | establishment of localization in cell | 3.94% (8/203) | 2.03 | 0.000867 | 0.003092 |
| GO:0012507 | ER to Golgi transport vesicle membrane | 0.99% (2/203) | 5.52 | 0.000911 | 0.003192 |
| GO:0030662 | coated vesicle membrane | 0.99% (2/203) | 5.52 | 0.000911 | 0.003192 |
| GO:0065003 | protein-containing complex assembly | 2.96% (6/203) | 2.45 | 0.000909 | 0.003213 |
| GO:0032561 | guanyl ribonucleotide binding | 2.46% (5/203) | 2.77 | 0.000932 | 0.003234 |
| GO:0005525 | GTP binding | 2.46% (5/203) | 2.77 | 0.000932 | 0.003234 |
| GO:0004519 | endonuclease activity | 2.46% (5/203) | 2.76 | 0.000951 | 0.003286 |
| GO:0030658 | transport vesicle membrane | 0.99% (2/203) | 5.48 | 0.000968 | 0.003317 |
| GO:0030532 | small nuclear ribonucleoprotein complex | 1.48% (3/203) | 3.98 | 0.000973 | 0.003319 |
| GO:0097525 | spliceosomal snRNP complex | 1.48% (3/203) | 3.98 | 0.000968 | 0.00333 |
| GO:1905369 | endopeptidase complex | 0.99% (2/203) | 5.43 | 0.001027 | 0.003488 |
| GO:0019001 | guanyl nucleotide binding | 2.46% (5/203) | 2.72 | 0.001063 | 0.003596 |
| GO:0031248 | protein acetyltransferase complex | 1.48% (3/203) | 3.93 | 0.001075 | 0.003606 |
| GO:1902493 | acetyltransferase complex | 1.48% (3/203) | 3.93 | 0.001075 | 0.003606 |
| GO:0004386 | helicase activity | 2.46% (5/203) | 2.68 | 0.001228 | 0.004103 |
| GO:0120114 | Sm-like protein family complex | 1.48% (3/203) | 3.85 | 0.00127 | 0.004226 |
| GO:0044249 | cellular biosynthetic process | 7.39% (15/203) | 1.29 | 0.001384 | 0.004584 |
| GO:0022607 | cellular component assembly | 3.45% (7/203) | 2.1 | 0.001407 | 0.004642 |
| GO:0005765 | lysosomal membrane | 0.99% (2/203) | 5.15 | 0.001517 | 0.004984 |
| GO:0098852 | lytic vacuole membrane | 0.99% (2/203) | 5.11 | 0.00159 | 0.0052 |
| GO:0035267 | NuA4 histone acetyltransferase complex | 0.99% (2/203) | 5.09 | 0.001645 | 0.005316 |
| GO:0043189 | H4/H2A histone acetyltransferase complex | 0.99% (2/203) | 5.09 | 0.001645 | 0.005316 |
| GO:0019538 | protein metabolic process | 12.32% (25/203) | 0.92 | 0.001637 | 0.005333 |
| GO:0030674 | protein-macromolecule adaptor activity | 1.48% (3/203) | 3.71 | 0.001668 | 0.005369 |
| GO:0051641 | cellular localization | 4.43% (9/203) | 1.74 | 0.001703 | 0.005458 |
| GO:0009742 | brassinosteroid mediated signaling pathway | 0.99% (2/203) | 4.95 | 0.001976 | 0.006282 |
| GO:0043401 | steroid hormone mediated signaling pathway | 0.99% (2/203) | 4.95 | 0.001976 | 0.006282 |
| GO:0003724 | RNA helicase activity | 1.48% (3/203) | 3.61 | 0.002032 | 0.006384 |
| GO:0008186 | ATP-dependent activity, acting on RNA | 1.48% (3/203) | 3.61 | 0.002032 | 0.006384 |
| GO:0051603 | proteolysis involved in protein catabolic process | 2.96% (6/203) | 2.22 | 0.002019 | 0.006393 |
| GO:0061630 | ubiquitin protein ligase activity | 1.97% (4/203) | 2.91 | 0.002141 | 0.006702 |
| GO:1902562 | H4 histone acetyltransferase complex | 0.99% (2/203) | 4.8 | 0.002424 | 0.007498 |
| GO:0051169 | nuclear transport | 1.97% (4/203) | 2.86 | 0.002422 | 0.00752 |
| GO:0006913 | nucleocytoplasmic transport | 1.97% (4/203) | 2.86 | 0.002422 | 0.00752 |
| GO:0016831 | carboxy-lyase activity | 1.48% (3/203) | 3.51 | 0.00245 | 0.007549 |
| GO:0061659 | ubiquitin-like protein ligase activity | 1.97% (4/203) | 2.85 | 0.002497 | 0.007664 |
| GO:0006357 | regulation of transcription by RNA polymerase II | 2.96% (6/203) | 2.16 | 0.002522 | 0.007712 |
| GO:0046540 | U4/U6 x U5 tri-snRNP complex | 0.99% (2/203) | 4.76 | 0.002583 | 0.007838 |
| GO:0006405 | RNA export from nucleus | 1.48% (3/203) | 3.49 | 0.002576 | 0.007846 |
| GO:0043933 | protein-containing complex organization | 3.45% (7/203) | 1.94 | 0.00265 | 0.007921 |
| GO:0050657 | nucleic acid transport | 1.48% (3/203) | 3.47 | 0.00265 | 0.007949 |
| GO:0051236 | establishment of RNA localization | 1.48% (3/203) | 3.47 | 0.00265 | 0.007949 |
| GO:0050658 | RNA transport | 1.48% (3/203) | 3.47 | 0.00265 | 0.007949 |
| GO:0016050 | vesicle organization | 1.48% (3/203) | 3.45 | 0.002763 | 0.008226 |
| GO:0098588 | bounding membrane of organelle | 2.96% (6/203) | 2.12 | 0.002837 | 0.008417 |
| GO:0016282 | eukaryotic 43S preinitiation complex | 0.49% (1/203) | 8.36 | 0.003036 | 0.008973 |
| GO:0140662 | ATP-dependent protein folding chaperone | 1.48% (3/203) | 3.4 | 0.003058 | 0.009004 |
| GO:0097526 | spliceosomal tri-snRNP complex | 0.99% (2/203) | 4.62 | 0.003089 | 0.009061 |
| GO:0098796 | membrane protein complex | 2.96% (6/203) | 2.08 | 0.003263 | 0.009538 |
| GO:0005484 | SNAP receptor activity | 0.99% (2/203) | 4.57 | 0.003319 | 0.009665 |
| GO:0060090 | molecular adaptor activity | 1.48% (3/203) | 3.34 | 0.003437 | 0.009973 |
| GO:0006906 | vesicle fusion | 0.99% (2/203) | 4.54 | 0.003476 | 0.01005 |
| GO:0005680 | anaphase-promoting complex | 0.99% (2/203) | 4.52 | 0.003556 | 0.010244 |
| GO:0051082 | unfolded protein binding | 1.48% (3/203) | 3.31 | 0.003648 | 0.010471 |
| GO:0031201 | SNARE complex | 0.99% (2/203) | 4.41 | 0.004141 | 0.011842 |
| GO:0043632 | modification-dependent macromolecule catabolic process | 2.46% (5/203) | 2.24 | 0.00447 | 0.012737 |
| GO:0044183 | protein folding chaperone | 1.48% (3/203) | 3.19 | 0.004571 | 0.012979 |
| GO:0035060 | brahma complex | 0.49% (1/203) | 7.72 | 0.004719 | 0.013351 |
| GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 0.99% (2/203) | 4.3 | 0.004797 | 0.013477 |
| GO:0005770 | late endosome | 0.99% (2/203) | 4.3 | 0.004797 | 0.013477 |
| GO:0031461 | cullin-RING ubiquitin ligase complex | 1.48% (3/203) | 3.12 | 0.005221 | 0.014563 |
| GO:0004176 | ATP-dependent peptidase activity | 0.99% (2/203) | 4.24 | 0.005207 | 0.014575 |
| GO:0042788 | polysomal ribosome | 0.49% (1/203) | 7.53 | 0.005391 | 0.014986 |
| GO:0000152 | nuclear ubiquitin ligase complex | 0.99% (2/203) | 4.21 | 0.005433 | 0.01505 |
| GO:0006084 | acetyl-CoA metabolic process | 0.99% (2/203) | 4.17 | 0.005698 | 0.015728 |
| GO:0044770 | cell cycle phase transition | 0.99% (2/203) | 4.15 | 0.005866 | 0.016081 |
| GO:0044772 | mitotic cell cycle phase transition | 0.99% (2/203) | 4.15 | 0.005866 | 0.016081 |
| GO:0033045 | regulation of sister chromatid segregation | 0.99% (2/203) | 4.14 | 0.005934 | 0.016212 |
| GO:0070603 | SWI/SNF superfamily-type complex | 0.99% (2/203) | 4.1 | 0.006244 | 0.017001 |
| GO:0070993 | translation preinitiation complex | 0.49% (1/203) | 7.21 | 0.006735 | 0.018211 |
| GO:0030623 | U5 snRNA binding | 0.49% (1/203) | 7.21 | 0.006735 | 0.018211 |
| GO:0051983 | regulation of chromosome segregation | 0.99% (2/203) | 4.03 | 0.00685 | 0.01846 |
| GO:0000380 | alternative mRNA splicing, via spliceosome | 0.49% (1/203) | 7.14 | 0.00707 | 0.018925 |
| GO:0032777 | piccolo histone acetyltransferase complex | 0.49% (1/203) | 7.14 | 0.00707 | 0.018925 |
| GO:0002926 | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation | 0.49% (1/203) | 7.01 | 0.007741 | 0.020651 |
| GO:0051168 | nuclear export | 1.48% (3/203) | 2.87 | 0.008337 | 0.022167 |
| GO:0015931 | nucleobase-containing compound transport | 1.48% (3/203) | 2.85 | 0.008695 | 0.023042 |
| GO:0090174 | organelle membrane fusion | 0.99% (2/203) | 3.84 | 0.008819 | 0.023293 |
| GO:0016830 | carbon-carbon lyase activity | 1.48% (3/203) | 2.84 | 0.008926 | 0.023497 |
| GO:0016571 | histone methylation | 0.99% (2/203) | 3.82 | 0.009107 | 0.023816 |
| GO:0005846 | nuclear cap binding complex | 0.49% (1/203) | 6.78 | 0.009081 | 0.023827 |
| GO:0031982 | vesicle | 1.97% (4/203) | 2.31 | 0.009167 | 0.023895 |
| GO:0031416 | NatB complex | 0.49% (1/203) | 6.72 | 0.009416 | 0.024463 |
| GO:0008299 | isoprenoid biosynthetic process | 1.48% (3/203) | 2.78 | 0.009864 | 0.025544 |
| GO:0071006 | U2-type catalytic step 1 spliceosome | 0.49% (1/203) | 6.62 | 0.010085 | 0.025863 |
| GO:0071012 | catalytic step 1 spliceosome | 0.49% (1/203) | 6.62 | 0.010085 | 0.025863 |
| GO:0016514 | SWI/SNF complex | 0.49% (1/203) | 6.62 | 0.010085 | 0.025863 |
| GO:0031625 | ubiquitin protein ligase binding | 0.99% (2/203) | 3.73 | 0.010169 | 0.02591 |
| GO:1904949 | ATPase complex | 0.99% (2/203) | 3.73 | 0.010169 | 0.02591 |
| GO:0010629 | negative regulation of gene expression | 1.97% (4/203) | 2.26 | 0.010245 | 0.026023 |
| GO:0042054 | histone methyltransferase activity | 0.99% (2/203) | 3.7 | 0.010608 | 0.026857 |
| GO:0044389 | ubiquitin-like protein ligase binding | 0.99% (2/203) | 3.7 | 0.010652 | 0.026884 |
| GO:0061025 | membrane fusion | 0.99% (2/203) | 3.69 | 0.010831 | 0.027248 |
| GO:0009057 | macromolecule catabolic process | 2.96% (6/203) | 1.71 | 0.010908 | 0.027356 |
| GO:0017070 | U6 snRNA binding | 0.49% (1/203) | 6.49 | 0.011088 | 0.027633 |
| GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) | 0.49% (1/203) | 6.49 | 0.011088 | 0.027633 |
| GO:0043412 | macromolecule modification | 9.85% (20/203) | 0.81 | 0.011257 | 0.027966 |
| GO:0035194 | regulatory ncRNA-mediated post-transcriptional gene silencing | 0.99% (2/203) | 3.63 | 0.011696 | 0.028876 |
| GO:0016441 | post-transcriptional gene silencing | 0.99% (2/203) | 3.63 | 0.011696 | 0.028876 |
| GO:0000123 | histone acetyltransferase complex | 0.99% (2/203) | 3.57 | 0.012542 | 0.030871 |
| GO:0097157 | pre-mRNA intronic binding | 0.49% (1/203) | 6.28 | 0.012757 | 0.031206 |
| GO:0004612 | phosphoenolpyruvate carboxykinase (ATP) activity | 0.49% (1/203) | 6.28 | 0.012757 | 0.031206 |
| GO:0006420 | arginyl-tRNA aminoacylation | 0.49% (1/203) | 6.25 | 0.013091 | 0.031633 |
| GO:0034515 | proteasome storage granule | 0.49% (1/203) | 6.25 | 0.013091 | 0.031633 |
| GO:0004814 | arginine-tRNA ligase activity | 0.49% (1/203) | 6.25 | 0.013091 | 0.031633 |
| GO:0036211 | protein modification process | 8.87% (18/203) | 0.84 | 0.013049 | 0.031822 |
| GO:0005768 | endosome | 1.48% (3/203) | 2.62 | 0.013279 | 0.031991 |
| GO:0016592 | mediator complex | 0.99% (2/203) | 3.51 | 0.013712 | 0.032933 |
| GO:0035383 | thioester metabolic process | 0.99% (2/203) | 3.5 | 0.013861 | 0.033092 |
| GO:0006637 | acyl-CoA metabolic process | 0.99% (2/203) | 3.5 | 0.013861 | 0.033092 |
| GO:0003712 | transcription coregulator activity | 1.48% (3/203) | 2.6 | 0.013922 | 0.033139 |
| GO:0004816 | asparagine-tRNA ligase activity | 0.49% (1/203) | 6.11 | 0.014424 | 0.033926 |
| GO:0009328 | phenylalanine-tRNA ligase complex | 0.49% (1/203) | 6.11 | 0.014424 | 0.033926 |
| GO:0006421 | asparaginyl-tRNA aminoacylation | 0.49% (1/203) | 6.11 | 0.014424 | 0.033926 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 1.97% (4/203) | 2.12 | 0.014339 | 0.034028 |
| GO:0017102 | methionyl glutamyl tRNA synthetase complex | 0.49% (1/203) | 6.04 | 0.01509 | 0.035283 |
| GO:0030619 | U1 snRNA binding | 0.49% (1/203) | 6.04 | 0.01509 | 0.035283 |
| GO:0033044 | regulation of chromosome organization | 0.99% (2/203) | 3.43 | 0.015185 | 0.035402 |
| GO:0030620 | U2 snRNA binding | 0.49% (1/203) | 5.89 | 0.016752 | 0.038941 |
| GO:0097361 | CIA complex | 0.49% (1/203) | 5.83 | 0.017416 | 0.040367 |
| GO:0031090 | organelle membrane | 2.96% (6/203) | 1.54 | 0.018546 | 0.042861 |
| GO:0010008 | endosome membrane | 0.99% (2/203) | 3.26 | 0.018892 | 0.043533 |
| GO:0004826 | phenylalanine-tRNA ligase activity | 0.49% (1/203) | 5.67 | 0.019406 | 0.044461 |
| GO:0006432 | phenylalanyl-tRNA aminoacylation | 0.49% (1/203) | 5.67 | 0.019406 | 0.044461 |
| GO:0019941 | modification-dependent protein catabolic process | 1.97% (4/203) | 1.98 | 0.019552 | 0.044666 |
| GO:0071044 | histone mRNA catabolic process | 0.49% (1/203) | 5.62 | 0.020069 | 0.045326 |
| GO:0071041 | antisense RNA transcript catabolic process | 0.49% (1/203) | 5.62 | 0.020069 | 0.045326 |
| GO:0071040 | nuclear polyadenylation-dependent antisense transcript catabolic process | 0.49% (1/203) | 5.62 | 0.020069 | 0.045326 |
| GO:0042868 | antisense RNA metabolic process | 0.49% (1/203) | 5.62 | 0.020069 | 0.045326 |
| GO:0016887 | ATP hydrolysis activity | 2.46% (5/203) | 1.7 | 0.020136 | 0.045349 |
| GO:0071039 | nuclear polyadenylation-dependent CUT catabolic process | 0.49% (1/203) | 5.58 | 0.020731 | 0.046036 |
| GO:0071037 | nuclear polyadenylation-dependent snRNA catabolic process | 0.49% (1/203) | 5.58 | 0.020731 | 0.046036 |
| GO:0016076 | snRNA catabolic process | 0.49% (1/203) | 5.58 | 0.020731 | 0.046036 |
| GO:0016077 | sno(s)RNA catabolic process | 0.49% (1/203) | 5.58 | 0.020731 | 0.046036 |
| GO:0071036 | nuclear polyadenylation-dependent snoRNA catabolic process | 0.49% (1/203) | 5.58 | 0.020731 | 0.046036 |
| GO:0006423 | cysteinyl-tRNA aminoacylation | 0.49% (1/203) | 5.53 | 0.021392 | 0.047242 |
| GO:0004817 | cysteine-tRNA ligase activity | 0.49% (1/203) | 5.53 | 0.021392 | 0.047242 |
| GO:0034504 | protein localization to nucleus | 0.99% (2/203) | 3.15 | 0.021835 | 0.047952 |
| GO:0006606 | protein import into nucleus | 0.99% (2/203) | 3.15 | 0.021835 | 0.047952 |
| GO:0051170 | import into nucleus | 0.99% (2/203) | 3.13 | 0.022261 | 0.048753 |
| GO:0002940 | tRNA N2-guanine methylation | 0.49% (1/203) | 5.47 | 0.022384 | 0.048888 |
| GO:0006720 | isoprenoid metabolic process | 1.48% (3/203) | 2.33 | 0.022618 | 0.04913 |
| GO:0005774 | vacuolar membrane | 0.99% (2/203) | 3.12 | 0.022567 | 0.049154 |
